David L. Suter (Dave)
Principal / Detroit Metro Office
With more than three decades of experience in intellectual property law, David brings a wealth of expertise to his work with individual, corporate, and university clients. David implements complex legal strategies in a variety of industries, including pharmaceuticals, consumer products, medical devices, and green technologies. His experience includes patent portfolio management, risk avoidance (including infringement and invalidity opinions), and trade secret management. David also negotiates and drafts complex IP agreements and advises on the IP due diligence aspects of M&As, having led IP due diligence investigations in the automotive, telecommunications, resource recovery, energy, consumer products, pharmaceutical, and medical device industries.
David offers extensive experience in the chemical, molecular biological, and mechanical fields. His abilities range from organic chemistry, pharmaceutical formulations, treatment regimens, biologics, diagnostics, and plants; to oral and personal care products, food technologies, nutritionals, and functional foods; to polymer chemistry, ceramics, electrochemistry, battery technology, hydrocarbon reformation, and optical materials.
In the News
- David Suter Interviewed by Law360 about Federal Circuit’s Plea for Patent Eligibility Help
- "Facebook Wants to Play Dating Game—Its Lawyers Could Face IP, Trade Secret Challenges," Corporate Counsel, May 17, 2018
- "Venture Capital Still Flowing to Life Sciences, Stoking Innovation," Bloomberg BNA, January 27, 2017
- "What Are Your IP Litigation Landmines?," Law360, September 11, 2015
- "Do The Proposed AIA Rule Changes Go Far Enough?," Law360, August 29, 2015
- “With High Court Mum on Java Copyrights, Is Innovation Safe?,” Law360, July 1,2015
David served as Associate General Counsel for The Procter & Gamble Company, where he was responsible for all IP matters pertaining to pharmaceuticals, oral care, beauty care and P&G’s new ventures business unit. A highlight of David’s career was his work with Dr. Barry Marshall, who was awarded the 2005 Nobel Prize in Medicine for his discovery of the role of the bacterium Helicobacter pylori in gastritis and peptic ulcer disease. David prosecuted Dr. Marshall’s patents on the use of bismuth salts for the treatment of H. pylori disorders. David has also served as an Adjunct Professor at the Michigan State University College of Law.
Awards & Distinctions
- Leading Lawyers, named a “Leading Lawyer” for Intellectual Property and Patents, 2014-2021
- Intellectual Asset Management (IAM), “Patent 1000, “2018-2022
J.D., with honors, Ohio State University, 1981
B.S., Chemistry and Physics, magna cum laude, Bowling Green State University, 1978
Bar & Court Admissions
U.S. Court of Appeals for the Federal Circuit
U.S. Patent and Trademark Office